Bruno Julianne 4
4 · CRISPR Therapeutics AG · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Bruno Julianne
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Shares
2024-06-20+7,000→ 10,111 total - Sale
Common Shares
2024-06-21$56.09/sh−3,366$188,799→ 6,745 total - Exercise/Conversion
Restricted Stock Units
2024-06-20−7,000→ 0 total→ Common Shares (7,000 underlying)
Holdings
- 7,088(indirect: The Julianne Bruno 2022 GRAT)
Common Shares
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- [F3]This restricted stock unit award was granted on December 14, 2021 with respect to 7,000 Common Shares, with 100% of the shares vesting on June 20, 2024.